BeStock  
Stocks › Medical Devices › INMD

InMode INMD

US equityMarket cap rank #3370Medical Devices
$12.42 −$0.28 (-2.20%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $12.32 -0.81%
Open$12.64
Prev close$12.70
Day range$12.40 – $12.69
Volume707.6K
Market cap$714.70M
P/E (TTM)10.4
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$92.14M-1.1% YoY
Operating profit$17.51M-16.2% YoY
Net profit$18.86M-13.7% YoY
Diluted EPS$0.32-5.9% YoY
Free cash flow$11.19M-54.0% YoY
Operating cash flow$11.38M

Revenue, last 8 quarters

$97.9MDec '24$77.9MMar '25$95.6MJun '25$93.2MSep '25$103.9MDec '25$82.0MMar '26$95.6MJun '26$92.1MSep '26

Net profit, last 8 quarters

$82.8MDec '24$18.2MMar '25$26.7MJun '25$21.9MSep '25$27.0MDec '25$11.6MMar '26$17.1MJun '26$18.9MSep '26

Diluted EPS by quarter

1.14Dec '240.26Mar '250.42Jun '250.34Sep '250.42Dec '250.18Mar '260.29Jun '260.32Sep '26

Free cash flow by quarter

$32.2MDec '24$14.0MMar '25$23.9MJun '25$24.3MSep '25$22.1MDec '25$15.2MMar '26$20.8MJun '26$11.2MSep '26

Annual revenue

$206.1MFY20$357.6MFY21$454.3MFY22$492.0MFY23$394.8MFY24$370.5MFY25

Profitability & balance sheet

Gross margin76.6%
Operating margin17.6%
Net margin19.9%
Return on equity11.4%
Return on assets10.1%
Return on invested capital11.3%
Current ratio8.58
Liabilities / assets12.1%
Cash & investments$512.73M
Total debt$3.58M
Net cash (debt)$509.15M
Free cash flow / sales18.6%

Where the revenue comes from

Quarter 2026/Q1

By business line

  • Minimal-Invasive$63.15M 77.0%
  • Non-Invasive$18.04M 22.0%
  • Hands-Free$820,170.00 1.0%

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Revenue as Reported $92.14M $95.59M $82.02M $370.50M $103.85M
Total Operating Revenue $92.14M $95.59M $82.02M $370.50M $103.85M
Cost of Revenue $20.34M $24.07M $20.47M $79.53M $22.55M
Gross Profit $71.79M $71.52M $61.55M $290.97M $81.30M
Operating Expense $54.29M $59.26M $51.50M $205.58M $55.31M
Selling and Admin Expenses $50.42M $55.60M $47.95M $192.26M $51.80M
-Selling & Marketing Expense $45.95M $50.82M $42.93M $180.58M $48.41M
-General & Admin Expense $4.47M $4.79M $5.02M $11.69M $3.39M
Research & Development $3.86M $3.66M $3.54M $13.32M $3.51M
Operating Profit $17.51M $12.26M $10.06M $85.39M $25.99M
Net Non-Operating Interest Income (Expense) $4.71M $7.43M $4.30M $24.94M $5.30M
Total Other Finance Costs -$4.71M -$7.43M – – –
Pretax Profit $22.22M $19.69M $14.35M $110.33M $31.29M
Tax $3.36M $2.63M $2.79M $16.50M $4.27M
Net Profit $18.86M $17.06M $11.56M $93.83M $27.03M
Profit from Continuing Operations $18.86M $17.06M $11.56M $93.83M $27.03M
Net Income to Parent Company $18.86M $17.06M $11.56M $93.83M $27.03M
Net Income to Common Stockholders $18.86M $17.06M $11.56M $93.83M $27.03M
Basic EPS $0.33 $0.29 $0.18 $1.45 $0.43
Diluted EPS $0.32 $0.29 $0.18 $1.43 $0.42
Non-Operating Interest Income – – $4.30M $24.94M –

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $740.48M $720.33M $750.84M $766.43M $766.43M
Total Current Assets $670.80M $650.00M $680.78M $698.62M $698.62M
Cash and Cash Equivalents & Short-Term Investments $512.73M $501.12M $537.16M $555.33M $555.33M
-Cash and Cash Equivalents $397.11M $396.17M $394.30M $302.54M $302.54M
-Short Term Investments $115.62M $104.94M $142.86M $252.79M $252.79M
Receivables $85.66M $77.22M $72.21M $49.28M $49.28M
-Accounts Receivable $49.96M $44.56M $40.70M $43.50M $43.50M
-Other Receivables $35.71M $32.66M $31.51M $1.83M $1.83M
Inventory $72.42M $71.66M $71.41M $74.05M $74.05M
Total Non-Current Assets $69.67M $70.34M $70.06M $67.81M $67.81M
Net PPE $10.77M $11.32M $11.23M $10.87M $10.87M
-Gross PPE $10.77M $11.32M $11.23M $15.75M $15.75M
Investments and Advances $700,000.00 $700,000.00 $700,000.00 $700,000.00 $700,000.00
Non Current Accounts Receivables $6.12M $5.69M $5.21M $3.01M $3.01M
Non-Current Deferred Assets $52.08M $52.63M $52.92M $53.23M $53.23M
Total Liabilities $89.26M $91.20M $89.58M $83.23M $83.23M
Total Current Liabilities $78.18M $79.44M $77.35M $70.74M $70.74M
Payables $17.91M $18.79M $16.85M $18.67M $18.67M
-Accounts Payable $17.91M $18.79M $16.85M $17.91M $17.91M
Current Deferred Liabilities $15.25M $15.45M $16.37M $12.09M $12.09M
Other Current Liabilities $45.03M $45.19M $44.13M $15.96M $15.96M
Total Non-Current Liabilities $11.08M $11.76M $12.23M $12.49M $12.49M
Long Term Debt and Capital Lease Obligation $3.58M $4.45M $4.83M $5.01M $5.01M
-Long Term Capital Lease Obligation $3.58M $4.45M $4.83M $5.01M $5.01M
Non-Current Deferred Liabilities $2.50M $2.48M $2.75M $3.04M $3.04M
Other Non-Current Liabilities $5.00M $4.83M $4.66M $4.44M $4.44M
Total Equity $651.22M $629.13M $661.25M $683.20M $683.20M
Stockholders' Equity $651.22M $629.13M $661.25M $683.20M $683.20M
-Taxes Receivable – – – $3.95M $3.95M
Prepaid Assets – – – $19.96M $19.96M
-Accumulated Depreciation – – – -$4.88M -$4.88M
-Long Term Equity Investment – – – $700,000.00 $700,000.00
-Total Tax Payable – – – $761,000.00 $761,000.00
Current Accrued Expenses – – – $1.71M $1.71M
Short-Term Debt and Capital Lease Obligation – – – $3.22M $3.22M
-Current Capital Lease Obligation – – – $3.22M $3.22M
Current Provisions – – – $931,000.00 $931,000.00
Capital Stock – – – $251,000.00 $251,000.00
-Common Stock – – – $251,000.00 $251,000.00
Additional Paid-In Capital – – – $209.62M $209.62M
Retained Earnings – – – $968.53M $968.53M
Less: Treasury Stock – – – -$495.27M -$495.27M
Gains/Losses Not Affecting Retained Earnings – – – $69,000.00 $69,000.00

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow $11.38M $21.05M $15.39M $85.26M $22.67M
Net cash flow from continuing operations $11.38M $21.05M $15.39M $85.26M $22.67M
Net Income from Continuing Operations $18.86M $17.06M $11.56M $93.83M $27.03M
Depreciation & Depletion & Amortization $232,000.00 $179,000.00 $175,000.00 $695,000.00 $174,000.00
Deferred Tax $554,000.00 $295,000.00 $327,000.00 $2.93M $864,000.00
Other Non-Cash Items -$890,000.00 $388,000.00 $719,000.00 $498,000.00 -$762,000.00
Change in Working Capital -$11.10M -$1.30M -$621,000.00 -$24.30M -$7.42M
-Change in Receivables -$9.46M -$6.21M -$5.79M -$11.13M -$7.63M
-Change in Inventory -$754,000.00 -$253,000.00 $2.64M -$14.50M -$2.65M
-Change in Payables and Accrued Expense -$887,000.00 $1.94M -$1.06M $4.13M $1.19M
-Change in Other Current Liabilities $189,000.00 $4.40M -$388,000.00 $2.16M $4.76M
-Change In Other Working Capital -$187,000.00 -$1.18M $3.98M -$4.96M -$3.09M
Net cash flow from investing -$10.75M $37.68M $109.10M $186.03M $27.22M
Net Cash Flow from Continuing Investing Activities -$10.75M $37.68M $109.10M $186.03M $27.22M
Net PPE Purchase and Sale -$195,000.00 -$211,000.00 -$172,000.00 -$972,000.00 -$534,000.00
Net Investment Purchase and Sale -$10.56M $37.90M $109.28M $187.00M $27.76M
Financing Cash Flow $97,000.00 -$56.49M -$32.43M -$126.06M $137,000.00
Net Cash Flow from Continuing Financing Activities $97,000.00 -$56.49M -$32.43M -$126.06M $137,000.00
Net Common Stock Issuance $0.00 -$56.51M -$31.24M -$127.44M $0.00
Proceeds from Stock Option Exercised $97,000.00 $19,000.00 $617,000.00 $1.39M $137,000.00
Ending Cash Balance $397.11M $396.17M $394.30M $302.54M $302.54M
Net Change in Cash $731,000.00 $2.24M $92.06M $145.23M $50.03M
Beginning Cash Balance $396.17M $394.30M $302.54M $155.33M $252.44M
Effect of Exchange Rate Changes $207,000.00 -$365,000.00 -$311,000.00 $1.98M $72,000.00
Free Cash Flow $11.19M $20.84M $15.21M $84.29M $22.14M
Net Other Financing Charges – – -$1.80M – –
Gain/Loss from Continuing Operations – – – $15,000.00 $1,000.00

Discussion

No comments yet — be the first to weigh in on INMD.

Sign in to join the discussion.

Scroll to Top